AveXis to Present at Piper Jaffray GenomeRX Symposium

Dallas, TX, June 20, 2014 --(PR.com)-- AveXis, a clinical stage synthetic biology platform company, today announced that Mr. John Carbona, Chief Executive Officer and other members of the AveXis team will participate in the panel discussion “The Power Alley: Gene Therapy For Neuromuscular Disorders” at the Piper Jaffray GenomeRX Symposium on Monday, June 23, 2014. The panel is scheduled to begin at 10:40 a.m. EDT and will take place at The Yale Club, New York, New York.